Inventor
BONE SCOTT
US24 patents
⚠️ This page may combine multiple inventors who share the name “BONE SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DECIPHERA PHARMACEUTICALS LLC
20 patentsUS11612591B2Mar 28, 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC31 citations97
US11395818B2Jul 26, 2022
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC36 citations97
US11185535B2Nov 30, 2021
Amorphous kinase inhibitor formulations and methods of use thereof
DECIPHERA PHARMACEUTICALS LLC39 citations97
US11801237B2Oct 31, 2023
Amorphous kinase inhibitor formulations and methods of use thereof
DECIPHERA PHARMACEUTICALS LLC13 citations94
US11793795B2Oct 24, 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC13 citations94
US11576903B2Feb 14, 2023
Amorphous kinase inhibitor formulations and methods of use thereof
DECIPHERA PHARMACEUTICALS LLC31 citations94
US12318374B2Jun 3, 2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US12226406B2Feb 18, 2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US12213968B2Feb 4, 2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US12213967B2Feb 4, 2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US12064422B2Aug 20, 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US12023328B2Jul 2, 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11969415B1Apr 30, 2024
(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11918564B1Mar 5, 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11911370B1Feb 27, 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11903933B2Feb 20, 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11896585B2Feb 13, 2024
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11850241B1Dec 26, 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11850240B1Dec 26, 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
US11844788B1Dec 19, 2023
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
DECIPHERA PHARMACEUTICALS LLC0 citations73
CELGENE CORP
4 patentsUS11701362B2Jul 18, 2023
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamide
CELGENE CORP0 citations61
US10898488B2Jan 26, 2021
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
CELGENE CORP0 citations61
US10653697B2May 19, 2020
Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
CELGENE CORP0 citations50
US10543214B2Jan 28, 2020
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
CELGENE CORP0 citations50